To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Kawasaki disease is the leading cause of acquired heart disease in children, and coronary artery aneurysms represent its most important cardiovascular complication. Identifying children at risk for coronary artery aneurysms at 4 to 8 weeks after disease onset is clinically important. Serum ferritin may reflect systemic inflammation in Kawasaki disease, but its incremental predictive value remains uncertain. This study developed a ferritin-based model for predicting coronary artery aneurysms at 4 to 8 weeks.
Methods:
Patients with Kawasaki disease were retrospectively identified at a single centre and randomly divided into training and internal validation cohorts in a 6:4 ratio. Predictors were selected using least absolute shrinkage and selection operator regression and multivariable logistic regression. Model performance was assessed by discrimination, calibration, decision curve analysis, and reclassification metrics.
Results:
Among 378 patients, 98 (25.9%) had coronary artery aneurysms at 4 to 8 weeks after disease onset. The ferritin-based model included male sex, platelet count, serum ferritin, albumin ≤ 31.5 g/L, and baseline maximum coronary artery Z score ≥ 2.5. Adding serum ferritin increased the area under the receiver operating characteristic curve from 0.853 to 0.899 in the training cohort and from 0.842 to 0.868 in the internal validation cohort, with good calibration, greater decision-curve net benefit, and improved risk reclassification.
Conclusions:
Serum ferritin provided incremental predictive value for coronary artery aneurysms at 4 to 8 weeks after the onset of Kawasaki disease. The ferritin-based model improved predictive performance in internal validation and warrants multicentre external validation to assess its generalisability and clinical applicability.
Belz and colleagues present GREAT, a seven-item clinical instrument for predicting electroconvulsive therapy response in unipolar depression, with promising discriminatory validity (AUC 0.841). We identify three methodological gaps – absent calibration, limited sample representativeness and unquantified incremental value – that must be addressed before GREAT can guide individual clinical decisions.
Bipolar disorder (BD) is frequently misdiagnosed as major depressive disorder (MDD), with diagnostic delays averaging 6–10 years leading to suboptimal treatment and poorer outcomes. Early identification of patients at risk for diagnostic conversion remains a critical clinical priority. We aimed to identify clinical predictors of BD conversion in a large population-based cohort and develop a clinically applicable prediction model.
Methods
We conducted a retrospective cohort study using electronic health records from the Catalan PADRIS-PRESTO database (2010–2019). Patients aged ≥18 years with incident MDD diagnosed in specialized mental health services (2015–2019) were followed until BD diagnosis, death, or study end. Time-varying Cox regression addressed proportional hazards violations, with competing risks analysis accounting for mortality.
Results
Among 52,001 patients (median follow-up 4.0 years), 3,958 (7.61%) converted to BD. Psychotic features emerged as the strongest predictor (HR = 3.18, 95% CI: 2.92–3.45, E-value = 5.82), with consistent effects across follow-up. Anxiety disorders showed time-varying protection (baseline HR = 0.41, 95% CI: 0.35–0.48) that attenuated over time (interaction HR = 1.30 per period). The time-varying model achieved good discrimination (C-index = 0.745). Machine learning validation confirmed predictor importance rankings (Spearman r = 0.87).
Conclusions
Psychotic features during depressive episodes robustly predict BD conversion, warranting enhanced clinical monitoring. Our time-varying prediction model using routinely collected clinical data enables early risk stratification to guide diagnostic vigilance and treatment decisions.
This real-world study aimed to characterize patients with schizophrenia who achieve sustained good functional outcomes after antipsychotic discontinuation and to develop the Functional Remission in Schizophrenia after Antipsychotic Discontinuation (FURSAD) predictive model.
Methods
We retrospectively identified individuals aged 18–65 years with schizophrenia (ICD-10) from the Shanghai Mental Health Center discharge database. Patients who discontinued antipsychotics for ≥1 year were classified as functional remission (FR) or functional non-remission (FNR) based on functioning assessments. Sociodemographic, clinical, and treatment-related data were extracted blindly from hospital records and structured interviews.
Results
Among 4,166 discharged patients screened, 180 met the inclusion criteria (FR: 116; FNR: 64). Six independent predictors were identified: total disease course, Clinical Global Impression-Severity (CGI-S) score, Positive and Negative Syndrome Scale (PANSS) emotional distress subscale score, use of first-generation antipsychotics, discontinuation due to treatment benefits, and discontinuation due to lack of insight. The logistic regression model showed strong predictive performance (AUC = 0.867, 95% CI 0.813–0.921), with 82.8% sensitivity and 81.9% specificity. Internal validation was performed via 10-fold cross-validation.
Conclusion
Discontinuation motives and illness trajectory are relevant in predicting long-term functional outcomes. A limitation is that a substantial number of patients could not be recontacted or declined participation, which may introduce selection bias. The FURSAD nomogram may help clinicians estimate the probability of FR 4.5 years post-antipsychotic discontinuation in patients previously on antipsychotics for ≥3 years.
Forensic psychiatric services are expanding in many countries, and discharging patients from secure hospitals relies on accurate estimates of risk of adverse outcomes. Novel evidence-based tools for estimating one key risk, violent reoffending, have been developed in recent years. We aimed to externally validate one new tool, FoVOx, in forensic psychiatric patients sentenced to treatment and to develop an updated model (FoVOx2), incorporating additional clinical predictors.
Methods
Using Swedish national registers, we conducted a temporal external validation of FoVOx by examining 767 patients discharged between 2014 and 2023. For the FoVOx2 cohort, 906 patients discharged between 2008 and 2023 were followed up, and additional predictors tested. The outcome was violent reconviction within 12 or 24 months. Model performance was evaluated using Harrell’s C-index, area under the receiver operating characteristics curves (AUCs), calibration, and classification metrics at predefined thresholds.
Results
In temporal validation, FoVOx showed moderate discrimination (AUCs 0.69 and 0.71; C-index = 0.69) and acceptable overall accuracy (Brier <0.11). Calibration was generally good, with mild overestimation at the highest predicted risks (>20%) at 12 months and slight underprediction at 24 months. The updated FoVOx2 model incorporated novel predictors, including clozapine treatment and additional diagnostic categories. It was associated with improved performance (AUCs 0.77; optimism-corrected C-index = 0.72; Brier 0.06 and 0.09) and demonstrated good calibration (intercept ≈ 0; slopes 1.03 and 1.05).
Conclusions
Updating risk assessment tools with additional clinical factors can lead to incremental improvement in model performance. Implementing tools should consider clinical utility and impact as next steps.
Secondary intracranial infections are common and severe complications in patients with viral encephalitis, contributing to higher mortality, prolonged hospitalization and increased healthcare burden. Evidence on risk factors, pathogen spectrum and resistance patterns remains limited, and predictive models tailored to this population are lacking.
Methods:
We conducted a single-center retrospective cohort study, including 160 consecutive patients diagnosed with viral encephalitis. Clinical, therapeutic, laboratory and microbiological data were extracted from hospital records. Independent risk factors were identified using multivariate logistic and Cox regression. Predictive performance was assessed by receiver operating characteristic analysis. Pathogen distribution and antimicrobial resistance profiles were analyzed descriptively.
Results:
During a median follow-up of 16 days, 50 patients (31.3%) developed secondary intracranial infections, corresponding to an incidence of 2.9 events per 1000 patient-days. Independent predictors included older age (adjusted OR 1.39 per 10 years, P = 0.021), comorbidities (OR 2.18, P = 0.048), corticosteroid use ≥7 days (OR 2.45, P = 0.025), ≥2 invasive procedures (OR 2.92, P = 0.007) and elevated CSF protein (OR 2.36, P = 0.037). The multivariable risk score achieved an area under the curve of 0.86 (95% CI 0.80–0.92). Pathogen analysis revealed methicillin-resistant Staphylococcus aureus (MRSA) (24.0%) and Acinetobacter baumannii (20.0%) as predominant isolates, both showing high multidrug resistance, including carbapenem resistance rates of 70% in A. baumannii.
Conclusion:
Secondary intracranial infections occur frequently in viral encephalitis and are strongly associated with host vulnerability. The predominance of MRSA and carbapenem-resistant A. baumannii underscores the urgent need for tailored infection control and antimicrobial strategies in neurocritical care.
Slotted blade technology is a passive flow control strategy that can effectively suppress the boundary layer separation within compressors. To reduce the iteration time of the traditional Design-Experiment-Design method, this study innovatively proposes a fast and universal three-dimensional design method for the slotted blade technology, enabling slot modeling completion within 1 s. Furthermore, combined with machine learning (ML), the mapping relationships between eight design parameters and two key aerodynamic performances – compressor design point efficiency ($\eta$DE) and stator total pressure recovery coefficient at the near-stall point ($\sigma ^{*}_{NS}$) – were pioneeringly established. In this study, the prediction performances of six models were compared: one-dimensional convolutional neural network (1D-CNN), random forest (RF), support vector regression (SVR), Gaussian process regression (GPR), multi-layer perceptron (MLP) and long short-term memory network (LSTM). The results indicate that 1D-CNN achieves the highest prediction accuracy: for the $\eta$DE, the mean absolute error (MAE) and coefficient of determination (R2) are 0.041 and 0.987, respectively; for the $\sigma ^{*}_{NS}$, the MAE and R² are 0.479 × 10−3 and 0.955, respectively. Notably, the computational time of the 1D-CNN model is 99.11% less than that of the computational fluid dynamics (CFD). The Shapley Additive exPlanations (SHAP) method was employed to reveal the effects of design parameters on the compressor aerodynamic performance. Notably, the slot outlet axial position (Zout) exerts the most significant influence on the $\eta$DE, while the slot outlet radial position close to the casing (R1_out) has the strongest impact on the $\sigma ^{*}_{NS}$. This study provides theoretical support and valuable references for the intelligent design of slotted blade technology.
Adequate protein intake is crucial for preventing frailty and sarcopenia in older adults, but conventional dietary assessments are time-consuming. Developing a rapid screening tool for identifying those at risk of low protein intake is essential; however, no such tool exists for Asian populations. This study developed a prediction model to identify older adults in Japan at risk of low protein intake using a simple food intake questionnaire. The model was developed using data from 4,085 older adults aged ≥65 years from the 2013 and 2017 National Health and Nutrition Surveys. Protein intake was assessed using a one-day dietary record with a semi-weighted method. A multivariable logistic regression model was developed to predict low protein intake (<1.0 g/kg adjusted body weight/day), incorporating sex, age, adjusted body weight, and food intake frequency of nine food groups. Model performance was evaluated using the area under the receiver operator characteristic (ROC) curve and a calibration plot, both adjusted for optimism through bootstrap resampling. Participants had a mean age of 74.1 years (standard deviation = 6.6), and 55.5% of all participants were female. The prevalence of low protein intake was 21.8%. Internal validation showed a bootstrap optimism-corrected ROC area of 0.695 and a calibration slope of 0.921. We developed a 12-item prediction model for identifying older adults at risk of low protein intake. The model provides a practical tool to identify older adults at high risk of low protein intake and is expected to be used in public health settings.
The association between geriatric depression and out-of-hospital cardiac arrest (OHCA) has not been fully clarified.
Aims
This study aimed to develop and validate a predictive model for OHCA in older patients through a longitudinal, population-based approach.
Method
This study analysed data from the National Health Insurance Research Database for the period 2011–2020, focusing on older patients both diagnosed with depression and treated with antidepressant medications. A multivariate logistic regression model was used to identify potential predictors of OHCA. Considering the effect of COVID-19, data-sets from 2019 and 2020 were used as external validation. The model’s performance was evaluated using receiver operating characteristic (ROC) curves and confusion matrix metrics.
Results
Out of 104 022 geriatric patients with depression, 2479 (2.4%) experienced OHCA. Significant predictors of OHCA included age, male gender, previous utilisation of medical resources, renal failure with haemodialysis, existing comorbidities, medication changes and recent psychotherapy. The ROC values for the predictive models ranged from 0.707 to 0.771 in the 2019 and 2020 external validations for 7-, 30- and 90-day OHCA. For 2019, the 7-day model demonstrated sensitivity, specificity, positive likelihood ratio, negative likelihood ratio and diagnostic odds ratio of 0.600, 0.718, 2.130, 0.560 and 3.840, respectively. For 2020, these metrics for the 7-day model were 0.775, 0.655, 2.250, 0.340 and 6.550, respectively.
Conclusion
This study developed and validated a predictive model for OHCA in older patients with depression. The model identified crucial predictors, providing valuable insights for psychiatrists and emergency clinicians to identify high-risk patients and implement early preventive measures.
A predictive column chart was developed to assess the risk of primary liver cancer (PLC) in hepatitis B patients. Data from 107 PLC patients and 107 controls were used as the training set, with 92 patients as the validation set. An additional 446 patients from other hospitals, including 15 with PLC, formed the external validation group. Multivariate logistic regression identified gender, BMI, alcohol consumption, diabetes, family history of liver cancer, cirrhosis, and HBV DNA load as independent risk factors. The model showed strong discrimination with AUCs of 0.882 and 0.859 in the training and validation sets, respectively, and good calibration (Hosmer–Lemeshow χ² = 2.648, P = 0.954; χ² = 4.117, P = 0.846). Decision curve analysis (DCA) confirmed clinical benefit within a risk threshold of 0.07–0.95. In the external validation group, the model maintained discrimination (AUC = 0.863) and calibration (Hosmer–Lemeshow χ² = 7.999, P = 0.434), with DCA showing net benefit across 0.14–0.95. These results indicate the column chart is a reliable tool for PLC risk prediction in hepatitis B patients.
In the absence of evidence-based therapeutic options for the majority of couples with recurrent pregnancy loss (RPL) it is considered significant to offer supportive care, including reliable counseling regarding the prognosis of subsequent pregnancies. Currently, various prediction models are available, with a focus on couples with unexplained RPL. All of them having drawbacks like substantial risk of bias, lack of performance measures and applicability. A new prediction model, using more predictors, such as male predictors and focusing on cumulative live birth rates over a reasonable time period is currently needed. In addition, this model should have the ability to provide reliable predictions at later time points, a so-called dynamic prediction model.
To enhance the capacity for early and effective management of genital tract infections at primary and secondary levels of the healthcare system, we developed a prediction model, validated internally to help predict individual risk of self-reported genital tract infections (sGTIs) at the community level in Ghana. The study involved 32973 men and women aged 15–49 years from three rounds of the Ghana Demographic Health Survey, from 2003 to 2014. The outcomes were sGTIs. We applied the least absolute shrinkage and selection operator (LASSO) penalized regression with a 10-fold cross-validation model to 11 predictors based on prior review of the literature. The bootstrapping technique was also employed as a sensitivity analysis to produce a robust model. We further employed discriminant and calibration analyses to evaluate the performance of the model. Statistical significance was set at P-value <0.05. The mean±standard deviation age was 29.1±9.7 years with female preponderance (60.7%). The prevalence of sGTIs within the period was 11.2% (95% CI = 4.5–17.8) and it ranged from 5.4% (95% CI = 4.8–5.86) in 2003 to 17.5% (95% CI = 16.4–18.7) in 2014. The LASSO regression model retained all 11 predictors. The model’s ability to discriminate between those with sGTIs and those without sGTIs was approximately 73.50% (95% CI = 72.50–74.26) from the area under the curve with bootstrapping technique. There was no evidence of miscalibration from the calibration belt plot with bootstrapping (test statistic = 17.30; P-value = 0.060). The model performance was judged to be good and acceptable. In the absence of clinical measurement, this prediction tool can be used to identify individuals aged 15–49 years with a high risk of sGTIs at the community level in Ghana. Frontline healthcare staff can use this tool for screening and early detection. We, therefore, propose external validation of the model to confirm its generalizability and reliability in different population.
The objective was to develop equations to predict carcass weight (CW), use CW to predict empty body weight (EBW); and carcass gain (CG) to predict empty body weight gain (EBWG) and retained energy (RE) in hair sheep. To generate the prediction models, a data set was composed of individual measurements from 569 sheep encompassing intact males (n = 416), castrated males (n = 51), and females (n = 102). Validation analyses were performed by using the Model Evaluation System (MES). The prediction equations for CW, EBW, and EBWG were not influenced by sex class (P > 0.05), and the following equations were generated, respectively: CW (kg) = − 0.234 (±1.1358) + 0.485 (±0.0387) × FBW; EBW (kg) = 1.367 (±0.5472) + 1.681 (±0.0210) × CW and EBWG (kg) = 0.004 (±0.0026) + 1.679 (±0.0758) × CG. There was an effect of sex class on the intercept (P = 0.0013) of the relationship between RE and CG: RE (MJ/day) = 1.448 (±0.0657) × EBW0.75 × CG0.797 (±0.0399); RE (MJ/day) = 1.522 (±0.0699) × EBW0.75 × CG0.797 (±0.0399) and RE (MJ/day) = 1.827 (±0.0739) × EBW0.75 × CG0.797 (±0.0399) for intact males, castrated males and females, respectively. This study highlights the importance of incorporating carcass information into EBW, EBWG, and RE predictions. Replacing empty body weight gain with carcass gain might be a suitable alternative to estimate the retained energy of hair sheep. In addition, the generated equations will provide support for meat production systems in carcass weight prediction.
To develop a machine learning model and nomogram to predict the probability of persistent virus shedding (PVS) in hospitalized patients with coronavirus disease 2019 (COVID-19), the clinical symptoms and signs, laboratory parameters, cytokines, and immune cell data of 429 patients with nonsevere COVID-19 were retrospectively reviewed. Two models were developed using the Akaike information criterion (AIC). The performance of these two models was analyzed and compared by the receiver operating characteristic (ROC) curve, calibration curve, net reclassification index (NRI), and integrated discrimination improvement (IDI). The final model included the following independent predictors of PVS: sex, C-reactive protein (CRP) level, interleukin-6 (IL-6) level, the neutrophil-lymphocyte ratio (NLR), monocyte count (MC), albumin (ALB) level, and serum potassium level. The model performed well in both the internal validation (corrected C-statistic = 0.748, corrected Brier score = 0.201) and external validation datasets (corrected C-statistic = 0.793, corrected Brier score = 0.190). The internal calibration was very good (corrected slope = 0.910). The model developed in this study showed high discriminant performance in predicting PVS in nonsevere COVID-19 patients. Because of the availability and accessibility of the model, the nomogram designed in this study could provide a useful prognostic tool for clinicians and medical decision-makers.
Monitoring population salt intake is operationally and economically challenging. We explored whether a questionnaire assessment and a prediction of Na intake from spot-urine could replace or complement the recommended measurement of Na in 24-h urine (24-h U).
Design:
Compare the agreement of a Na-specific food record checklist (FRCL) and a late-afternoon spot-urine measurement (PM-spot) with 24-h U measurement in estimating Na intake at group level. Each participant’s use of these methods extended over 3 d. Agreement was assessed using mean (95 % CI) differences, linear regression models and Bland–Altman plots.
Setting:
The validation study was part of a 1-year workplace intervention trial to lower salt intake in Switzerland.
Participants:
Seventy women and 71 men, aged 21–61 years, completed three FRCL, and acceptable PM-spot and 24-h U samples at baseline (April–October 2015).
Results:
Mean Na intake estimates varied slightly across methods (3·5–3·9 g/d). Mean Na intake differences from 24-h U were 0·2 (95 % CI (0, 0·5)) g/d for FRCL and 0·4 (95 % CI (0·2, 0·6)) g/d for PM-spot. Linear regression models and Bland–Altmann plots more clearly depicted differences by sex and discretionary salt use.
Conclusions:
Although 24-h U remains the best reference method for monitoring Na intake at the population level, PM-spot and FRCL might be more practical instruments for frequent, periodic Na intake assessments. Population-specific prediction models to estimate 24-h U could be developed and evaluated.
In many countries, depressed individuals often first visit primary care settings for consultation, but a considerable number of clinically depressed patients remains unidentified. Introducing additional screening tools may facilitate the diagnostic process.
Objectives
This study aims to examine whether Experience Sampling Method (ESM)-based measures of depressive affect and behaviors can discriminate depressed from non-depressed individuals. In addition, the added value of actigraphy-based measures was examined.
Methods
We used data from two samples to develop and validate prediction models. The development dataset included 14 days of ESM and continuous actigraphy of currently depressed (n=43) and non-depressed individuals (n=82). The validation dataset included 30 days of ESM and continuous actigraphy of currently depressed (n=27) and non-depressed individuals (n=27). Backward stepwise logistic regression analyses were applied to build the prediction models. The performance of the models was assessed with the goodness of fit indices, calibration curves, and discriminative ability (AUC, the area under the receiver operating characteristic curve).
Results
In the development dataset, the discriminative ability was good for the actigraphy model (AUC=0.790) and excellent for the ESM (AUC=0.991) and combined-domains model (AUC=0.993). In the validation dataset, the discriminative ability was reasonable for the actigraphy model (AUC=0.648) and excellent for the ESM (AUC=0.891) and combined-domains model (AUC=0.892).
Conclusions
ESM is a good diagnostic predictor and is easy to calculate, and, therefore, holds promise for implementation in clinical practice. Actigraphy shows no added value to ESM as a diagnostic predictor, but might still be useful when active monitoring with ESM is not feasible.
Predicting the need for hospitalisation of patients with coronavirus disease 2019 (COVID-19) is important for preventing healthcare disruptions. This observational study aimed to use the COVID-19 Registry Japan (COVIREGI-JP) to develop a simple scoring system to predict respiratory failure due to COVID-19 using only underlying diseases and symptoms. A total of 6873 patients with COVID-19 admitted to Japanese medical institutions between 1 June 2020 and 2 December 2020 were included and divided into derivation and validation cohorts according to the date of admission. We used multivariable logistic regression analysis to create a simple risk score model, with respiratory failure as the outcome for young (18–39 years), middle-aged (40–64 years) and older (≥65 years) groups, using sex, age, body mass index, medical history and symptoms. The models selected for each age group were quite different. Areas under the receiver operating characteristic curves for the simple risk score model were 0.87, 0.79 and 0.80 for young, middle-aged and elderly derivation cohorts, and 0.81, 0.80 and 0.67 in the validation cohorts. Calibration of the model was good. The simple scoring system may be useful in the appropriate allocation of medical resources during the COVID-19 pandemic.
Numerous predictive models for the risk of type 2 diabetes mellitus (T2DM) exist, but a minority of them has implemented nutrition data so far, even though the significant effect of nutrition on the pathogenesis, prevention and management of T2DM has been established. Thus, in the present study, we aimed to build a predictive model for the risk of T2DM that incorporates nutrition data and calculates its predictive performance. We analysed cross-sectional data from 1591 individuals from the population-based Cooperative Health Research in the Region of Augsburg (KORA) FF4 study (2013–14) and used a bootstrap enhanced elastic net penalised multivariate regression method in order to build our predictive model and select among 193 food intake variables. After selecting the significant predictor variables, we built a logistic regression model with these variables as predictors and T2DM status as the outcome. The values of area under the receiver operating characteristic (ROC) curve, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of our predictive model were calculated. Eleven out of the 193 food intake variables were selected for inclusion in our model, which yielded a value of area under the ROC curve of 0⋅79 and a maximum PPV, NPV and accuracy of 0⋅37, 0⋅98 and 0⋅91, respectively. The present results suggest that nutrition data should be implemented in predictive models to predict the risk of T2DM, since they improve their performance and they are easy to assess.
Epidemic forecasting provides an opportunity to predict geographic disease spread and counts when an outbreak occurs and plays a key role in preventing or controlling their adverse impact. However, conventional prediction models based on complex mathematical modelling rely on the estimation of model parameters, which yields unreliable and unsustainable results. Herein, we proposed a simple model for predicting the epidemic transmission dynamics based on nonlinear regression of the epidemic growth rate and iterative methods, which is applicable to the progression of the COVID-19 outbreak under the strict control measures of the Chinese government. Our model yields reliable and accurate results as confirmed by the available data: we predicted that the total number of infections in mainland China would be 91 253, and the maximum number of beds required for hospitalised patients would be 62 794. We inferred that the inflection point (when the growth rate turns from positive to negative) of the epidemic across China would be mid-February, and the end of the epidemic would be in late March. This model is expected to contribute to resource allocation and planning in the health sector while providing a theoretical basis for governments to respond to future global health crises or epidemics.
Most of the existing prediction models for COVID-19 lack validation, are inadequately reported or are at high risk of bias, a reason which has led to discourage their use. Few existing models have the potential to be extensively used by healthcare providers in low-resource settings since many require laboratory and imaging predictors. Therefore, we sought to develop and validate a multivariable prediction model of death in Mexican patients with COVID-19, by using demographic and patient history predictors. We conducted a national retrospective cohort study in two different sets of patients from the Mexican COVID-19 Epidemiologic Surveillance Study. Patients with a positive reverse transcription-polymerase chain reaction for SARS-CoV-2 and complete unduplicated data were eligible. In total, 83 779 patients were included to develop the scoring system through a multivariable Cox regression model; 100 000, to validate the model. Eight predictors (age, sex, diabetes, chronic obstructive pulmonary disease, immunosuppression, hypertension, obesity and chronic kidney disease) were included in the scoring system called PH-Covid19 (range of values: −2 to 25 points). The predictive model has a discrimination of death of 0.8 (95% confidence interval (CI) 0.796–0.804). The PH-Covid19 scoring system was developed and validated in Mexican patients to aid clinicians to stratify patients with COVID-19 at risk of fatal outcomes, allowing for better and efficient use of resources.